| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |
| 07/13/2000 | WO2000040962A1 Cyclodextrin polymers for use as drug carriers |
| 07/13/2000 | WO2000040742A1 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/13/2000 | WO2000040696A1 Preservation of sensitive biological materials at ambient temperatures by vitrification |
| 07/13/2000 | WO2000040616A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/13/2000 | WO2000040592A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | WO2000040591A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | WO2000040270A2 Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28 |
| 07/13/2000 | WO2000040269A2 Pharmaceutical compositions for treatment of diseased tissues |
| 07/13/2000 | WO2000040265A1 Potentiation of anti-cd38-immunotoxin cytotoxicity |
| 07/13/2000 | WO2000040264A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 07/13/2000 | WO2000040262A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 07/13/2000 | WO2000040259A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 07/13/2000 | WO2000040254A1 Pharmaceutical composition for oral administration having therapeutic activity on gastrointestinal disorders |
| 07/13/2000 | WO2000040253A1 Synthetic, highly charged molecules and uses thereof |
| 07/13/2000 | WO2000040250A1 Amelometasone lotion |
| 07/13/2000 | WO2000040238A1 Pharmaceutical formulations of taxanes |
| 07/13/2000 | WO2000040236A1 Stabile and sterile emulsion which contains taxanes, and method for the production thereof |
| 07/13/2000 | WO2000040234A1 Topical anesthesia of the urinary bladder |
| 07/13/2000 | WO2000040232A2 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions |
| 07/13/2000 | WO2000040228A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 07/13/2000 | WO2000040224A1 Multiparticulate oral dosage forms |
| 07/13/2000 | WO2000040223A1 Hydroxypropylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings |
| 07/13/2000 | WO2000040220A1 Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same |
| 07/13/2000 | WO2000040219A1 Dispersible concentrate for the delivery of cyclosporin |
| 07/13/2000 | WO2000040203A2 Polymeric delivery agents and delivery agent compounds |
| 07/13/2000 | WO2000040172A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | WO2000019976A3 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/13/2000 | WO2000010582A3 Probiotic, lactic acid-producing bacteria and uses thereof |
| 07/13/2000 | WO2000006534A9 Compounds and compositions for delivering active agents |
| 07/13/2000 | WO2000003737A9 Water-soluble drugs and methods for their production |
| 07/13/2000 | CA2360032A1 Preservation of sensitive biological materials at ambient temperatures by vitrification |
| 07/13/2000 | CA2359892A1 Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41 |
| 07/13/2000 | CA2358570A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | CA2358495A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 07/13/2000 | CA2358463A1 Polymeric delivery agents and delivery agent compounds |
| 07/13/2000 | CA2358435A1 Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28 |
| 07/13/2000 | CA2358430A1 Potentiation of anti-cd38-immunotoxin cytotoxicity |
| 07/13/2000 | CA2358427A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 07/13/2000 | CA2357986A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | CA2356368A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | CA2355829A1 Multiparticulate oral dosage forms |
| 07/13/2000 | CA2322293A1 Hydroxypropylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings |
| 07/12/2000 | EP1018363A1 Nanoemulsion based on sequenced copolymers of ethylene oxyde and propylene oxyde and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology |
| 07/12/2000 | EP1018345A1 Water soluble dry compositions |
| 07/12/2000 | EP1018344A2 HLA-restricted hepatitis B virus CTL epitopes |
| 07/12/2000 | EP1018342A2 Diagnosis and treatment of bacterial dysentery |
| 07/12/2000 | EP1018340A1 Inclusion aminoacid salts compounds of benzimidazole derivatives with cyclodextrins, their preparation and pharmaceutical formulations containing them |
| 07/12/2000 | EP1018337A2 Formulations containing chlorhexidine, novel chlorhexidine salts,solutions containing the aforesaid chlorhexidine salts and their use |
| 07/12/2000 | EP1017836A2 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 07/12/2000 | EP1017790A1 Methods and compositions for binding hematopoietic stem cells |
| 07/12/2000 | EP1017720A1 Site-directed chemotherapy of metastases |
| 07/12/2000 | EP1017696A1 Acidic addition salts of morphine alkaloids and the application thereof |
| 07/12/2000 | EP1017419A1 Fucosyl gm1-klh conjugate vaccine against small cell lung cancer |
| 07/12/2000 | EP1017416A1 Treatment of cardiomyopathy |
| 07/12/2000 | EP1017413A1 LIQUID INTERFERON-$g(b) FORMULATIONS |
| 07/12/2000 | EP1017411A1 COMPOSITIONS SUITABLE FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS |
| 07/12/2000 | EP1017403A1 Use of zinc hyaluronate against peptic ulcer |
| 07/12/2000 | EP1017397A1 Photosensitizer conjugates for pathogen targeting |
| 07/12/2000 | EP1017386A1 GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE |
| 07/12/2000 | EP1017380A1 Topical non-steroidal anti-inflammatory drug composition |
| 07/12/2000 | EP1017371A4 Controlled release of drugs delivered by sublingual or buccal administration |
| 07/12/2000 | EP1017371A1 Controlled release of drugs delivered by sublingual or buccal administration |
| 07/12/2000 | EP1017368A2 Self-binding shearform compositions |
| 07/12/2000 | EP1017367A1 Methods for fabricating polymer-based controlled release preparions |
| 07/12/2000 | EP1017366A1 Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| 07/12/2000 | EP1017364A1 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 07/12/2000 | EP1017363A1 Taste masking for unpalatable formulations |
| 07/12/2000 | EP1017334A1 Methods and compositions for producing a cooling effect in tissues |
| 07/12/2000 | EP1017283A1 Polynucleotide vaccine formulations |
| 07/12/2000 | EP0918545B1 Tumour therapy |
| 07/12/2000 | EP0676952B1 Bioerodible controlled delivery system |
| 07/12/2000 | EP0662000B1 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
| 07/12/2000 | EP0635027B1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
| 07/12/2000 | CN1260006A Complex formation between dsDNA and oligomer of heterocycles |
| 07/12/2000 | CN1259875A Pharmaceutical compositions contg. anti-body-enzyme conjugates in combination with prodrugs |
| 07/12/2000 | CN1259874A Vaginal lactobacillus medicant |
| 07/12/2000 | CN1259871A Method of treating chronic progressive vascular scarring diseases |
| 07/12/2000 | CN1259870A Fatty emulsing contg. reducing sugar and method for sterilizing same |
| 07/12/2000 | CN1259343A Air pressed package using polyoxyethylene glyceryl oleate |
| 07/12/2000 | CN1259342A Air pressed package using polyoxyethylene glyceryl oleate |
| 07/12/2000 | CN1054282C Stabilized medicinal aerosol solution formulations |
| 07/11/2000 | US6088613 Method of magnetic resonance focused surgical and therapeutic ultrasound |
| 07/11/2000 | US6087486 Dna molecules encoding rip-1 protein which binds to the human immunodeficiency virus viral protein r; viricides and prophylactic agents |
| 07/11/2000 | US6087482 Heteroatomic oligonucleoside linkages |
| 07/11/2000 | US6087479 Introducing into patient a medical device of which at least a portion includes a nitric oxide adduct which may be a sodium nitroprusside, a nitrosothiol, a nitrate, a nitrite or a nitrosated amino acid |
| 07/11/2000 | US6087465 Melt-processible poly (ester urethane) and a process for the preparation thereof |
| 07/11/2000 | US6087396 A stable aqueous oxybutynin chloride solution can be placed in an infuser device for treatment of bladder dysfunction |
| 07/11/2000 | US6087391 Complexing with a carrier fatty acid esters of polyhydric hydroxyalkanes; for use in pharmaceuticals, cosmetics, foodstuffs and feeds, diet supplements and natural medicines; fat soluble, stable |
| 07/11/2000 | US6087375 Methods of treating or preventing thromboses |
| 07/11/2000 | US6087362 Treating erectile dysfunction in a human patients by administering prior to sexual activity |
| 07/11/2000 | US6087354 Gallium complexes of 3-hydroxy-4-pyrones to treat cancer |
| 07/11/2000 | US6087344 A pharmaceutical composition for effective drug delivery through skin or exposed tissue of a human |
| 07/11/2000 | US6087342 Substrates having bound polysaccharides and bacterial nucleic acids |
| 07/11/2000 | US6087340 A physiologically acceptable acidic solution of epirubicin hydrochloride dissolved in a physiologically acceptable solvent; free of freeze drying |
| 07/11/2000 | US6087338 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 07/11/2000 | US6087328 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 07/11/2000 | US6087325 Peptide-lipid conjugates |
| 07/11/2000 | US6087109 Antisense agent which associated with a heat stable toxin receptor; for diagnosis and prevention of intestinal cancers in humans; anticarcinogenic agents . |
| 07/11/2000 | US6087087 Treatment of hemoglobin with nitric oxide |